BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34989291)

  • 1. Assessment of efficacy and safety of UV-based therapy for psoriasis: a network meta-analysis of randomized controlled trials.
    Li Y; Cao Z; Guo J; Li Q; Zhu W; Kuang Y; Chen X
    Ann Med; 2022 Dec; 54(1):159-169. PubMed ID: 34989291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of UV-based therapy for psoriasis.
    Almutawa F; Alnomair N; Wang Y; Hamzavi I; Lim HW
    Am J Clin Dermatol; 2013 Apr; 14(2):87-109. PubMed ID: 23572293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
    Beani JC; Jeanmougin M
    Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():11-21. PubMed ID: 22512676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability.
    Ashcroft DM; Li Wan Po A; Williams HC; Griffiths CE
    Arch Dermatol; 2000 Dec; 136(12):1536-43. PubMed ID: 11115167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Bai F; Li GG; Liu Q; Niu X; Li R; Ma H
    J Immunol Res; 2019; 2019():2546161. PubMed ID: 31583255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis.
    Grundmann-Kollmann M; Ludwig R; Zollner TM; Ochsendorf F; Thaci D; Boehncke WH; Krutmann J; Kaufmann R; Podda M
    J Am Acad Dermatol; 2004 May; 50(5):734-9. PubMed ID: 15097957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of phototherapy protocols for psoriasis treatment.
    Lapolla W; Yentzer BA; Bagel J; Halvorson CR; Feldman SR
    J Am Acad Dermatol; 2011 May; 64(5):936-49. PubMed ID: 21429620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital ultraviolet therapy: a novel therapeutic approach for the targeted treatment of psoriasis vulgaris.
    Werfel T; Holiangu F; Niemann KH; Schmerling O; Lüllau F; Zedler A; Sträter HD; Niebuhr M
    Br J Dermatol; 2015 Mar; 172(3):746-53. PubMed ID: 25307476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches.
    Karrer S; Eholzer C; Ackermann G; Landthaler M; Szeimies RM
    Dermatology; 2001; 202(2):108-15. PubMed ID: 11306830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of psoralen - UVA photochemotherapy versus narrow band UVB phototherapy in the treatment of psoriasis.
    Tahir R; Mujtaba G
    J Coll Physicians Surg Pak; 2004 Oct; 14(10):593-5. PubMed ID: 15456547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
    Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of psoriasis by UVB and PUVA phototherapy].
    Beani JC
    Rev Prat; 1991 Oct; 41(22):2177-9. PubMed ID: 1784919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
    Trott J; Gerber W; Hammes S; Ockenfels HM
    Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A network meta-analysis for the comparison of efficacy and safety of interleukin (IL)-23 targeted drugs in the treatment of moderate to severe psoriasis.
    Shi J; Xu J; Chen Y
    Dermatol Ther; 2020 Jul; 33(4):e13802. PubMed ID: 32521069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.
    Phan K; Ramachandran V; Fassihi H; Sebaratnam DF
    JAMA Dermatol; 2019 Mar; 155(3):335-341. PubMed ID: 30698622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of targeted UVB phototherapy and calcipotriene versus targeted UVB alone in psoriasis: systematic review and meta-analysis of randomized controlled trials.
    Gu X; Shen M; Zhao S; Chen X
    J Dermatolog Treat; 2022 Feb; 33(1):100-104. PubMed ID: 32419530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of localized phototherapy and photodynamic therapy for psoriasis: a systematic review and meta-analysis.
    Almutawa F; Thalib L; Hekman D; Sun Q; Hamzavi I; Lim HW
    Photodermatol Photoimmunol Photomed; 2015 Jan; 31(1):5-14. PubMed ID: 24283358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D analogs combined with different types of phototherapy in the treatment of vitiligo: A systematic review of randomized trials and within-patient studies.
    Liu X; Yao Z; Wang Y; Chai L; Zhou X
    Int Immunopharmacol; 2022 Aug; 109():108789. PubMed ID: 35468365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.